Young adult leukemia, lymphoma survivors more distressed than older survivors
the ONA take:
According to two new studies published in the Journal of Psychosocial Oncology, researchers from University of Colorado Cancer Center in Denver, Colorado, have found that young adult survivors of leukemia and lymphoma are more likely to report high stress compared with older survivors of the same diseases.
Specifically, researchers found that 45% of patients aged 18-39 years old reported moderate-to-high distress, while 18% of those over 65 years reported the same level of distress. Neither group's distress was affected by time since cancer treatment.
The first study surveyed 477 cancer survivors. Researchers found that survivors under age 40 had the highest prevalence of distress, mostly due patients' fear of cancer recurrence. Survivors were also concerned with the high financial burden.
The second study interviewed 51 survivors of leukemia to better understand their reasons for high distress. Some patients were concerned about the financial burden, while others stressed about how long it would take to fully recover both physically and mentally.
The findings reinforce the importance of identifying those who are most likely to experience elevated stress levels and to understand their reasons for concern so that targeted interventions can be implemented.
Young adult survivors of leukemia and lymphoma are more likely to report high stress compared with older survivors of the same diseases.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|